|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2007-04-03 Option Award |
2007-04-04 5:01 pm | BARRIER THERAPEUTICS INC | BTRX | NOMIDES CHARLES (Chief R&D Officer) | 8,333 | $6.87 | $57,248 | 90,833 (Direct) | View |
| 2006-12-06 Option Award |
2006-12-08 8:01 pm | BARRIER THERAPEUTICS INC | BTRX | NOMIDES CHARLES (Chief R&D Officer) | 7,500 | $7.43 | $55,725 | 82,500 (Direct) |
View |
| Transaction & Date | Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2007-04-03 Option Award | 2007-04-04 5:01 pm |
2007-04-03 2017-04-03 | BARRIER THERAPEUTICS INC | BTRX | NOMIDES CHARLES (Chief R&D Officer) | 25,000 | $6.87 | 25,000 (Direct) | View |
| 2006-12-06 Option Award | 2006-12-08 8:01 pm | 2006-12-06 2016-12-06 | BARRIER THERAPEUTICS INC | BTRX | NOMIDES CHARLES (Chief R&D Officer) | 22,500 | $7.43 | 22,500 (Direct) |
View |
| 2006-03-31 Option Award |
2006-04-04 3:30 pm | 2006-03-31 2016-03-31 |
BARRIER THERAPEUTICS INC | BTRX | NOMIDES CHARLES (Chief R&D Officer) | 10,000 | $9.68 | 10,000 (Direct) | View |
| 2005-04-01 Option Award | 2005-04-04 4:45 pm |
2005-04-01 2015-04-01 | BARRIER THERAPEUTICS INC | BTRX | NOMIDES CHARLES (Chief Operating Officer) | 15,000 | $15.52 | 15,000 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 18:28:10 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |